ID

33819

Beschrijving

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study); ODM derived from: https://clinicaltrials.gov/show/NCT02175966

Link

https://clinicaltrials.gov/show/NCT02175966

Trefwoorden

Versies (1)
  1. 28-12-18 28-12-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

28 december 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hepatitis C NCT02175966

Engels

Eligibility Hepatitis C NCT02175966

1 Formulieren  
Criteria
Beschrijving

Criteria

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females ≥18 years of age, inclusive
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
chronic hcv infection genotype 1 only
Beschrijving

Chronic Hepatitis C Genotype

Datatype

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C0017431
non-cirrhotic
Beschrijving

Liver Cirrhosis Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
treatment naive subjects with no previous exposure to an interferon formulation (ie, ifnα, pegifnα), ribavirin (rbv) or hcv direct acting antiviral (daa) (protease, polymerase inhibitor, etc.)
Beschrijving

Therapy naive | Absence Exposure to Interferon | Absence Exposure to Interferon-alpha | Absence Exposure to Peginterferon alfa-2a | Absence Exposure to Peginterferon alfa-2b | Absence Exposure to Ribavirin | Absence Exposure to Direct Acting Anti-hepatitis C (HCV) Agents | Absence Exposure to Proteases | Absence Exposure to Polymerase Inhibitor

Datatype

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C3652465
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0332157
UMLS CUI [3,3]
C0002199
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0332157
UMLS CUI [4,3]
C0391001
UMLS CUI [5,1]
C0332197
UMLS CUI [5,2]
C0332157
UMLS CUI [5,3]
C0796545
UMLS CUI [6,1]
C0332197
UMLS CUI [6,2]
C0332157
UMLS CUI [6,3]
C0035525
UMLS CUI [7,1]
C0332197
UMLS CUI [7,2]
C0332157
UMLS CUI [7,3]
C4324239
UMLS CUI [8,1]
C0332197
UMLS CUI [8,2]
C0332157
UMLS CUI [8,3]
C0030940
UMLS CUI [9,1]
C0332197
UMLS CUI [9,2]
C0332157
UMLS CUI [9,3]
C1335439
UMLS CUI [9,4]
C1999216
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
hcv genotype other than genotype 1
Beschrijving

Hepatitis C virus genotype Except Genotype 1

Datatype

boolean

Alias
UMLS CUI [1,1]
C1148363
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C3532919
documented or suspected hepatocellular carcinoma
Beschrijving

Liver carcinoma Documented | Liver carcinoma Suspected

Datatype

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C1301725
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0750491
evidence of decompensated liver disease
Beschrijving

Decompensated liver disease

Datatype

boolean

Alias
UMLS CUI [1]
C4075847
contraindication(s) to peg/rbv therapy
Beschrijving

Medical contraindication Peginterferon | Medical contraindication Ribavirin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0982327
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0035525
Terug naar het begin van de pagina

Similar models

Eligibility Hepatitis C NCT02175966

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Age
Item
males and females ≥18 years of age, inclusive
boolean
C0001779 (UMLS CUI [1])
Chronic Hepatitis C Genotype
Item
chronic hcv infection genotype 1 only
boolean
C0524910 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
Liver Cirrhosis Absent
Item
non-cirrhotic
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Therapy naive | Absence Exposure to Interferon | Absence Exposure to Interferon-alpha | Absence Exposure to Peginterferon alfa-2a | Absence Exposure to Peginterferon alfa-2b | Absence Exposure to Ribavirin | Absence Exposure to Direct Acting Anti-hepatitis C (HCV) Agents | Absence Exposure to Proteases | Absence Exposure to Polymerase Inhibitor
Item
treatment naive subjects with no previous exposure to an interferon formulation (ie, ifnα, pegifnα), ribavirin (rbv) or hcv direct acting antiviral (daa) (protease, polymerase inhibitor, etc.)
boolean
C0919936 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C3652465 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0332157 (UMLS CUI [3,2])
C0002199 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0332157 (UMLS CUI [4,2])
C0391001 (UMLS CUI [4,3])
C0332197 (UMLS CUI [5,1])
C0332157 (UMLS CUI [5,2])
C0796545 (UMLS CUI [5,3])
C0332197 (UMLS CUI [6,1])
C0332157 (UMLS CUI [6,2])
C0035525 (UMLS CUI [6,3])
C0332197 (UMLS CUI [7,1])
C0332157 (UMLS CUI [7,2])
C4324239 (UMLS CUI [7,3])
C0332197 (UMLS CUI [8,1])
C0332157 (UMLS CUI [8,2])
C0030940 (UMLS CUI [8,3])
C0332197 (UMLS CUI [9,1])
C0332157 (UMLS CUI [9,2])
C1335439 (UMLS CUI [9,3])
C1999216 (UMLS CUI [9,4])
Item Group
C0680251 (UMLS CUI)
Hepatitis C virus genotype Except Genotype 1
Item
hcv genotype other than genotype 1
boolean
C1148363 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C3532919 (UMLS CUI [1,3])
Liver carcinoma Documented | Liver carcinoma Suspected
Item
documented or suspected hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1,1])
C1301725 (UMLS CUI [1,2])
C2239176 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Decompensated liver disease
Item
evidence of decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Medical contraindication Peginterferon | Medical contraindication Ribavirin
Item
contraindication(s) to peg/rbv therapy
boolean
C1301624 (UMLS CUI [1,1])
C0982327 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial